SPT Labtech与10X Genomics联手实现单细胞工作流程自动化 - 医学新闻
SPT Labtech and 10X Genomics partner to automate single cell workflows - News-Medical
#Genomics partner#SPT Labtech#automate single#single cell#cell workflows
生命科学资讯
生物技术与制药领域的最新动态
Illumina星座映射读取技术在GeneDx试点中揭示难以察觉的基因组信息 - PR新闻通讯社
Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot - PR Newswire
#technology uncovers#genomic insights#Illumina constellation#constellation mapped#mapped read
Illumina推出5碱基解决方案，推动多组学发现，实现基因组与表观基因组同步解析
Illumina fuels multiomic discovery with launch of 5-base solution, unlocking simultaneous genomic and epigenomic insights - Illumina
#unlocking simultaneous#Illumina fuels#fuels multiomic#multiomic discovery#simultaneous genomic
赛默飞世尔科技以31亿美元收购Olink后，其股价是否具有吸引力？- 雅虎财经
Is Thermo Fisher Scientific Attractively Priced After Recent $3.1 Billion Olink Acquisition? - Yahoo Finance
#Billion Olink#Olink Acquisition#Thermo Fisher#Fisher Scientific#Scientific Attractively
Thermo Fisher Scientific (TMO)财报预期增长：下周发布前需知要点 - 雅虎财经
Thermo Fisher Scientific (TMO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance
#Fisher Scientific#Earnings Expected#Week Release#Yahoo Finance#Thermo Fisher
罗氏获FDA批准阿尔茨海默症生物标志物血液检测技术——Fierce Biotech报道
Roche nabs FDA clearance for Alzheimer's biomarker blood test - Fierce Biotech
#Fierce Biotech#nabs FDA#FDA clearance#Alzheimer biomarker#Roche nabs
FDA批准罗氏Elecsys pTau181检测用于排除阿尔茨海默病相关淀粉样蛋白病理
FDA Clears Roche’s Elecsys pTau181 Test for Ruling Out Alzheimer-Related Amyloid Pathology - NeurologyLive
#Clears Roche#FDA Clears#Amyloid Pathology#Alzheimer-Related Amyloid#Elecsys
罗氏Elecsys® pTau181血液检测成为FDA批准的首个可用于初级保健排除阿尔茨海默病相关淀粉样蛋白病变的检测方法——PR Newswire报道。
Roche's Elecsys® pTau181 becomes the only FDA-cleared blood test for use in primary care to rule out Alzheimer's-related amyloid pathology - PR Newswire
#Roche Elecsys#amyloid pathology#FDA-cleared blood#blood test#primary care
罗氏与礼来阿尔茨海默症诊断血液检测获美国批准 - 路透社
Roche, Lilly's blood test for Alzheimer's diagnosis gets US approval - Reuters
#Lilly blood#Alzheimer diagnosis#blood test#Reuters Roche#Lilly
沃特世推出电荷检测质谱技术，加速下一代生物治疗药物研发进程 - 美通社
Waters Launches Charge Detection Mass Spectrometry Technology to Accelerate the Development of Next-Generation Biotherapeutics - PR Newswire
#Launches Charge#Charge Detection#Detection Mass#Mass Spectrometry#Spectrometry Technology
雅虎财经：Illumina（ILMN）推出BioInsight及高管团队变动后的估值观察
A Look at Illumina’s (ILMN) Valuation Following the Launch of BioInsight and Executive Team Updates - Yahoo Finance
#Executive Team#Team Updates#Yahoo Finance#Updates Yahoo#ILMN
现在是审视龙沙集团股份公司（VTX:LONN）的良机吗？——雅虎财经
Is Now An Opportune Moment To Examine Lonza Group AG (VTX:LONN)? - Yahoo Finance
#Opportune Moment#Examine Lonza#Lonza Group#VTX#LONN
罗氏与OASES携手推动基层医疗转型与创新，巩固香港全球医疗枢纽地位 - 美通社
Roche Collaborates with OASES to Drive Primary Healthcare Transformation and Innovation, Strengthening Hong Kong's Position as a Global Healthcare Hub - PR Newswire
#Strengthening Hong#Drive Primary#Hong Kong#Kong Position#Primary Healthcare
10x Genomics将于2025年11月6日公布2025年第三季度财务业绩 - 雅虎财经
10x Genomics to Report Third Quarter 2025 Financial Results on November 6, 2025 - Yahoo Finance
#Yahoo Finance#Financial Results#Genomics#Quarter#Financial
Parse Biosciences宣布Scale Biosciences（现为10x Genomics）专利无效 - 商业电讯
Parse Biosciences Invalidates Scale Biosciences (now 10x Genomics) Patent - Business Wire
#Invalidates Scale#Biosciences Invalidates#Scale Biosciences#Business Wire#Parse Biosciences
投资者如何看待10x Genomics（TXG）在先进基因组学工具中的专利失效问题 - 雅虎财经
How Investors May Respond To 10x Genomics (TXG) Patent Invalidation in Advanced Genomics Tools - Yahoo Finance
#Patent Invalidation#Advanced Genomics#Genomics Tools#Yahoo Finance#Tools Yahoo
龙沙集团：增长迹象与估值过高，新管理层带来不确定性 - 寻求阿尔法
Lonza Group: Growth, Signs Of Overvaluation, And A New Management Cause Uncertainty - Seeking Alpha
#Lonza Group#Seeking Alpha#Uncertainty Seeking#Growth#Alpha Lonza
龙沙集团在瑞士斯坦完成新药品灌装生产线建设——合同制药报道
Lonza Completes New Drug Product Filling Line in Stein, Switzerland - Contract Pharma
#Drug Product#Product Filling#Filling Line#Contract Pharma#Lonza Completes
报告：监管与政策变动引发生物制药行业领袖忧虑——来自《激烈制药》
Regulatory, policy disruptions are causing consternation among biopharma leaders: report - Fierce Pharma
#Fierce Pharma#policy disruptions#biopharma leaders#Pharma Regulatory#causing consternation
沃特世公司(WAT)股价今日上涨原因解析 - 雅虎财经
Why Waters Corporation (WAT) Stock Is Up Today - Yahoo Finance
#Waters Corporation#Yahoo Finance#Today Yahoo#WAT#Corporation